Fenwick & West represented Corium International, Inc. (NAS: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, in its…
Corium International’s $20 Million Follow-On Offering
![](https://globallegalchronicle.com/wp-content/uploads/2017/03/31cc2e97f3.jpeg)